Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB
Clinical trial NCT01392911 · COMPLETED
Trial details
- NCT number
- NCT01392911
- Sponsor
- Radboud University Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2018-07-01
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.